Machino-Ohtsuka Tomoko, Igarashi Miyako, Kawamatsu Naoto, Ishizu Tomoko
Department of Cardiology, Faculty of Medicine, University of Tsukuba, 1-1-1, Tennoudai, Tsukuba, Ibaraki 3058575, Japan.
Department of Clinical Laboratory Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 3058575, Japan.
Eur Heart J Case Rep. 2025 Apr 8;9(4):ytaf170. doi: 10.1093/ehjcr/ytaf170. eCollection 2025 Apr.
Dextro-transposition of the great arteries (d-TGA) typically results in death within the first year of life without surgery. Shunts can allow sufficient blood mixing and survival into adulthood; however, survival of patients with unrepaired d-TGA beyond 60 years has not been reported.
A 60-year-old woman with unrepaired d-TGA, an unrestricted atrial septal defect, and partial anomalous pulmonary venous return presented with recurrent syncope due to atrial tachycardia (AT) following two sessions of radiofrequency catheter ablation (RFCA) and sinus node dysfunction. She had a history of recurrent heart failure (HF) because of severe systemic right ventricle (sRV) dysfunction and tricuspid regurgitation. Multiple inducible ATs persisted even after repeated RFCA, making pacemaker implantation (PMI) and anti-arrhythmic therapy the preferred options. Although transvenous lead implantation was relatively contraindicated due to the presence of an intracardiac shunt, transvenous DDD PMI was deemed the most viable option considering the patient's fragile haemodynamic state. Pacing studies indicated that sRV pacing was superior to left ventricular septal pacing, as it reduced the QRS duration and improved RV synchrony. Following successful sRV septal lead implantation and atrioventricular delay (AVD) optimization, HF symptoms improved, ATs were suppressed with amiodarone, and syncope resolved. The patient remained stable for 2 years with no thromboembolic events under apixaban therapy and no HF or arrhythmia recurrence.
Although continuous close monitoring is warranted, endocardial pacing, AVD optimization, and medication enabled effective stabilization over 2 years in this rare case of unrepaired d-TGA with bradytachyarrhythmia and sRV dysfunction.
大动脉右位转位(d-TGA)如不进行手术,通常会在出生后第一年内死亡。分流术可使血液充分混合,从而使患者存活至成年;然而,尚未有未修复的d-TGA患者存活超过60岁的报道。
一名60岁女性,患有未修复的d-TGA、非限制性房间隔缺损和部分肺静脉异位引流,在接受两次射频导管消融术(RFCA)后因房性心动过速(AT)和窦房结功能障碍出现反复晕厥。她有因严重的系统性右心室(sRV)功能障碍和三尖瓣反流导致的反复心力衰竭(HF)病史。即使在反复进行RFCA后,仍存在多种可诱发的AT,因此起搏器植入(PMI)和抗心律失常治疗成为首选方案。尽管由于存在心内分流,经静脉导线植入相对禁忌,但考虑到患者脆弱的血流动力学状态,经静脉双腔双感知起搏器植入术被认为是最可行的选择。起搏研究表明,sRV起搏优于左心室间隔起搏,因为它可缩短QRS波时限并改善右心室同步性。成功植入sRV间隔导线并优化房室延迟(AVD)后,HF症状改善,胺碘酮抑制了AT,晕厥得以缓解。在阿哌沙班治疗下,患者保持稳定状态2年,未发生血栓栓塞事件,也未出现HF或心律失常复发。
尽管需要持续密切监测,但在这例罕见的未修复d-TGA合并缓慢性心律失常和sRV功能障碍的病例中,心内膜起搏、AVD优化和药物治疗使其在2年内实现了有效的病情稳定。